Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations.
Stellaromics is currently in the advanced stages of developing its Pyxa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases.
For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.
Company Details
- Employees
- 49
- Founded
- -
- Address
- 321 Harrison Ave 6th Floor, Boston,massachusetts 02118,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.stellaromics.com
- Keywords
- Spatial transcriptomics, Genomics, Multi-omics, Functional genomics, RNA therapeutics, Small RNA detection.
- HQ
- Boston, Massachusetts
Stellaromics Inc. Questions
Stellaromics Inc.'s website is http://www.stellaromics.com
Stellaromics Inc.'s LinkedIn profile is https://www.linkedin.com/company/stellaromics
Stellaromics Inc. has
49 employees.
View email and phone details for 49
employees at Stellaromics Inc..
Stellaromics Inc.'s industry is
Biotechnology Research
Stellaromics Inc.'s top competitors are
Pledge Therapeutics,
Scismic,
Nona Biosciences,
Qld Biotherapeutics Inc,
Marengo Therapeutics,
Oddity Labs,
1910 Genetics,
Manifold Bio,
Seaport Therapeutics,
Incendia Therapeutics.
Stellaromics Inc.'s categories are Biotechnology Research
Stellaromics Inc.'s founding year is 2022
